Viridian Therapeutics, Inc.\DE Balance Sheet (2013-2026) | VRDN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)	138.88M	42.30M	30.86M	31.29M	344.21M	155.58M	88.52M	87.08M	111.60M	102.83M	91.64M	107.67M	200.32M	99.59M	116.22M	117.32M	169.65M	212.38M	176.35M	164.99M
Receivables - Net (Quarter)	1.00M	0.45M	0.52M	0.69M	0.40M	0.10M	0.13M	0.10M	0.10M	0.10M	0.10M		0.01M
Receivables - Other (Quarter)	0.48M																70.00M			75.00M
Receivables (Quarter)	1.48M	0.45M	0.52M	0.69M	0.40M	0.10M	0.13M	0.10M	0.10M	0.10M	0.10M		0.01M
Inventory (Quarter)
Prepaid Assets (Quarter)	3.65M	2.75M	3.44M	4.25M	5.63M	6.52M	8.62M	11.94M	10.73M	9.01M	13.53M	10.30M	14.10M	20.88M	20.61M	15.39M	11.01M	19.58M	22.56M	24.74M
Current Assets (Quarter)	217.94M	200.16M	179.39M	166.15M	437.36M	431.17M	382.60M	346.33M	323.84M	486.48M	626.82M	581.66M	767.36M	738.46M	657.24M	578.75M	571.91M	894.23M	784.74M	1,081.27M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.35M	0.38M	0.69M	0.75M	0.82M	1.33M	1.59M	1.88M	1.80M	1.67M	1.53M	1.51M	1.29M	1.24M	1.16M	1.09M	1.12M	1.23M	1.13M	2.77M
Other Non-Current Assets (Quarter)																				1.11M
Intangibles (Quarter)																				10.00M
Non-Current Assets (Quarter)																				15.96M
Goodwill & Intangibles (Quarter)																				10.00M
Assets (Quarter)																				1,097.23M
Liabilities
Current Liabilities
Accounts Payables (Quarter)																				8.65M
Notes Payables (Quarter)
Payables (Quarter)																				8.65M
Accumulated Expenses (Quarter)																				55.14M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)												2.96M				8.44M
Current Leases (Quarter)
Current Deferred Revenue (Quarter)	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M
Total Current Liabilities (Quarter)																				63.79M
Non-Current Liabilities
Non-Current Debt (Quarter)																				113.64M
Non-Current Deffered Revenue (Quarter)		1.15M	1.08M	1.00M	0.93M	0.86M	0.79M	0.72M	0.65M	0.57M	0.50M	0.43M	0.36M	0.28M	0.21M	0.14M
Preferred Stock Liabilities (Quarter)
Convertible Debt (Quarter)																				242.16M
Other Non-Current Liabilities (Quarter)																				13.69M
Total Non-Current Liabilities (Quarter)																				421.45M
Total Liabilities (Quarter)																				435.14M
Shareholder's Equity
Total Debt (Quarter)																				113.64M
Common Equity (Quarter)																				662.10M
Liabilities and Shareholders Equity (Quarter)																				1,097.23M
Retained Earnings (Quarter)																				2,134.57M
Preferred Shares (Quarter)																				60.43M
Treasury Shares (Quarter)																				1.83M

Research Tools

Datasets

Plans

Developers

Viridian Therapeutics, Inc.\DE Balance Sheet (2013-2026) | VRDN

Research Tools

Datasets

Plans

Developers

Viridian Therapeutics, Inc.\DE Balance Sheet (2013-2026) | VRDN

Create an account

Sign In

Reset Password